ProCE Banner Activity

Express Points
State-of-the-Art Care for Patients With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Slideset Download
Download these summary slides from a live Webinar for expert insight on the management of patients with NF1 and plexiform neurofibromas including the latest evidence on MEK inhibitors for these patients.

Released: June 23, 2021

Expiration: June 22, 2022

No longer available for credit.

Share

Faculty

Scott Plotkin

Scott Plotkin, MD, PhD

Professor of Neurology
Division of Neuro-Oncology
Harvard Medical School
Neurologist
Department of Neurology
Massachusetts General Hospital
Boston, Massachusetts

Brian D. Weiss

Brian D. Weiss, MD

Clinical Professor of Pediatrics
Division of Oncology
Cancer and Blood Diseases Institute
Cincinnati Childrens Hospital Medical Center
Medical Director, Solid Tumor Program
Division of Oncology
Cincinnati Childrens Hospital
Cincinnati, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Scott Plotkin, MD, PhD

Professor of Neurology
Division of Neuro-Oncology
Harvard Medical School
Neurologist
Department of Neurology
Massachusetts General Hospital
Boston, Massachusetts

Brian D. Weiss, MD

Clinical Professor of Pediatrics
Division of Oncology
Cancer and Blood Diseases Institute
Cincinnati Childrens Hospital Medical Center
Medical Director, Solid Tumor Program
Division of Oncology
Cincinnati Childrens Hospital
Cincinnati, Ohio